Deferred leasing costs, net 119,699 129,322
Deferred loan costs, net 17,052 17,608
Prepaid expenses 4,608 3,627
Other assets 31,959 16,039
Total assets $3,008,162 $2,692,642
LIABILITIES AND STOCKHOLDERS' EQUITY
Mortgage notes payable, net $397,341 $403,836
Secured construction loan 389,904 286,355
Secured term loan 250,000 250,000
Exchangeable senior notes 175,000 175,000
Unsecured line of credit 216,847 228,165
Security deposits 7,513 7,704
Dividends and distributions payable 25,557 19,847
Accounts payable, accrued expenses, and other
liabilities 81,195 62,602
Acquired below-market leases, net 25,220 25,101
Total liabilities 1,568,577 1,458,610
Minority interests 19,269 19,319
Stockholders' equity:
Preferred stock, $.01 par value, 15,000,000
shares authorized: 7.375% Series A cumulative
redeemable preferred stock, $230,000,000
liquidation preference ($25.00 per share),
9,200,000 shares issued and outstanding at
September 30, 2007 222,413 -
Common stock, $.01 par value, 100,000,000
shares authorized, 65,465,839 and 65,425,598
shares issued and outstanding at September
30, 2007 and December 31, 2006, respectively 655
'/>"/>
| SOURCE BioMed Realty Trust, Inc. Copyright©2007 PR Newswire. All rights reserved |